Showing results (221-230 of 249) with videos related to

Sort By:
Pageof 25
Immunogenetics|June 12, 2008
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapyRafael Carretero, José M Romero, Francisco Ruiz-Cabello, et al.
International Journal of Cancer|July 11, 2007
Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune responseLaura Paco, Angel Miguel Garcia-Lora, Carlos Casares, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2006
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccinationTeresa Cabrera, Ester Lara, José M Romero, et al.
Journal of Translational Medicine|November 18, 2017
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016Paolo A Ascierto, Sanjiv S Agarwala, Gennaro Ciliberto, et al.
Molecular & Cellular Proteomics : MCP|July 2, 2003
Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer researchJulio E Celis, Pavel Gromov, Irina Gromova, et al.
BMC Cancer|December 23, 2008
Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancerPablo Sáenz-López, Rafael Carretero, José Manuel Cózar, et al.
Frontiers in Immunology|December 16, 2020
Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 SubsetJuan Francisco Gutiérrez-Bautista, Antonio Rodriguez-Nicolas, Antonio Rosales-Castillo, et al.
Oncotarget|January 18, 2019
Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patientsPaola Montes, Martin Kerick, Mónica Bernal, et al.
Cancer Immunology, Immunotherapy : CII|October 16, 2007
Characterization of HLA class I altered phenotypes in a panel of human melanoma cell linesRosa Méndez, Teresa Rodríguez, Ana Del Campo, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2019
Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progressionPaola Montes, Mónica Bernal, Laura N Campo, et al.
Pageof 25